| Varying degrees of amplification of the N-ras oncogene in the human breast cancer cell line MCF-7. | breast, |
| Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. | lung, |
| [Low incidence of point mutation of N-ras oncogene in human gliomas]. | glioma, |
| Metastatic epithelioid sarcoma with an N-ras oncogene mutation. | sarcoma, |
| Point mutations in the N-ras oncogene in malignant melanoma and congenital naevi. | skin, |
| Expression of interleukin 1 alpha, interleukin 6, and tumor necrosis factor alpha genes in human melanoma clones is associated with that of mutated N-RAS oncogene. | skin, |
| Amplification of c-MYC oncogene and point mutation of N-RAS oncogene point mutation in acute myelocytic leukemias with double minute chromosomes. | leukemia, |
| Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. | skin, |
| N-ras oncogene expression changes the growth characteristics of human melanoma in two independent SCID-hu mouse models. | skin, |
| Concomitant point mutation of tumor suppressor gene p53 and oncogene c-N-ras in malignant neuroendocrine pancreatic tumor. | pancreatic, |
| N-RAS oncogene mutations in patients with agnogenic myeloid metaplasia in leukemic transformation. | leukemia, |
| Mucinous cystadenocarcinoma of the spleen presenting a point mutation of the Kirsten-ras oncogene at codon 12. | None |
| Rapid mutational analysis of N-ras proto-oncogene in hematologic malignancies: study of 77 Greek patient. | None |
| Multiple stages of malignant transformation of human endothelial cells modelled by co-expression of telomerase reverse transcriptase, SV40 T antigen and oncogenic N-ras. | None |
| The N-ras proto-oncogene can suppress the malignant phenotype in the presence or absence of its oncogene. | None |
| Inhibition of DNA synthesis by carvacrol in mouse myoblast cells bearing a human N-RAS oncogene. | None |
| N-ras oncogene activation in a patient with gamma heavy chain disease. | None |
| Overexpression of the N-ras proto-oncogene, not somatic mutational activation, associated with malignant tumors in transgenic mice. | None |
| The effect of retinoic acid on chemosensitivity of PA-1 human teratocarcinoma cells and its modulation by an activated N-ras oncogene. | None |
| A high frequency of N-RAS oncogene mutations in multiple myeloma. | None |